These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2399411)

  • 1. Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor.
    Gibson JP; Yarrington JT; Loudy DE; Gerbig CG; Hurst GH; Newberne JW
    Toxicol Pathol; 1990; 18(2):225-38. PubMed ID: 2399411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential neuropathology of dogs treated with vigabatrin, a GABA-transaminase inhibitor.
    Yarrington JT; Gibson JP; Dillberger JE; Hurst G; Lippert B; Sussman NM; Heydorn WE; Marler RJ
    Toxicol Pathol; 1993; 21(5):480-9. PubMed ID: 8115824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of vigabatrin.
    Sabers A; Gram L
    Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral toxicity of vigabatrin in immature rats: characterization of intramyelinic edema.
    Walzer M; Bekersky I; Wanaski S; Collins S; Jortner B; Patterson R; Garman R; Sagar S; Tolbert D
    Neurotoxicology; 2011 Dec; 32(6):963-74. PubMed ID: 21473881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM; Armijo JA
    Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats.
    Butler WH; Ford GP; Newberne JW
    Toxicol Pathol; 1987; 15(2):143-8. PubMed ID: 3616399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI monitoring of vigabatrin-induced intramyelinic edema in dogs.
    Weiss KL; Schroeder CE; Kastin SJ; Gibson JP; Yarrington JT; Heydorn WE; McBride RG; Sussman NM; Arezzo JC
    Neurology; 1994 Oct; 44(10):1944-9. PubMed ID: 7936252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high-dose gamma-vinyl GABA (vigabatrin) administration on visual and somatosensory evoked potentials in dogs.
    Schroeder CE; Gibson JP; Yarrington J; Heydorn WE; Sussman NM; Arezzo JC
    Epilepsia; 1992; 33 Suppl 5():S13-25. PubMed ID: 1425496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin.
    John RA; Rimmer EM; Williams J; Cole G; Fowler LJ; Richens A
    Biochem Pharmacol; 1987 May; 36(9):1467-73. PubMed ID: 3579985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
    Saletu B; Grünberger J; Linzmayer L; Schwartz JJ; Haegele KD; Schechter PJ
    Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of vigabatrin.
    Graham D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):43S-45S. PubMed ID: 2757908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.
    Grant SM; Heel RC
    Drugs; 1991 Jun; 41(6):889-926. PubMed ID: 1715266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
    Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
    Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vigabatrin on brain and platelet GABA-transaminase activities.
    Bolton JB; Rimmer E; Williams J; Richens A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):35S-42S. PubMed ID: 2757907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of vigabatrin.
    Schechter PJ
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):19S-22S. PubMed ID: 2667604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropathology of vigabatrin.
    Butler WH
    Epilepsia; 1989; 30 Suppl 3():S15-7. PubMed ID: 2767014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug.
    Rimmer E; Kongola G; Richens A
    Br J Clin Pharmacol; 1988 Feb; 25(2):251-9. PubMed ID: 3358887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies of the influence of vigabatrin on the GABA system.
    Gram L; Larsson OM; Johnsen A; Schousboe A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):13S-17S. PubMed ID: 2757904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
    Jolkkonen J; Mazurkiewicz M; Lahtinen H; Riekkinen P
    Eur J Pharmacol; 1992 Dec; 229(2-3):269-72. PubMed ID: 1490526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.